| Multicenter Australian trial of islet transplantation: improving accessibility and outcomes PJ O'connell, DJ Holmes‐Walker, D Goodman, WJ Hawthorne, ... American Journal of Transplantation 13 (7), 1850-1858, 2013 | 127 | 2013 |
| Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease KL Graham, RM Sutherland, SI Mannering, Y Zhao, J Chee, ... The review of diabetic studies: RDS 9 (4), 148, 2012 | 86 | 2012 |
| Characteristics of TCR repertoire associated with successful immune checkpoint therapy responses J Kidman, N Principe, M Watson, T Lassmann, RA Holt, AK Nowak, ... Frontiers in Immunology 11, 587014, 2020 | 72 | 2020 |
| Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes J Chee, HJ Ko, A Skowera, G Jhala, T Catterall, KL Graham, ... The Journal of Immunology 192 (2), 572-580, 2014 | 62 | 2014 |
| Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ... Frontiers in Immunology 11, 584423, 2020 | 53 | 2020 |
| TNF receptor 1 deficiency increases regulatory T cell function in nonobese diabetic mice J Chee, E Angstetra, L Mariana, KL Graham, EM Carrington, ... The Journal of Immunology 187 (4), 1702-1712, 2011 | 52 | 2011 |
| Combination immune checkpoint blockade as an effective therapy for mesothelioma VS Fear, C Tilsed, J Chee, CA Forbes, T Casey, JN Solin, SM Lansley, ... Oncoimmunology 7 (10), e1494111, 2018 | 45 | 2018 |
| Transient Treg depletion enhances therapeutic anti‐cancer vaccination SA Fisher, WJ Aston, J Chee, A Khong, AL Cleaver, JN Solin, S Ma, ... Immunity, inflammation and disease 5 (1), 16-28, 2017 | 43 | 2017 |
| Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies S Li, Y Simoni, S Zhuang, A Gabel, S Ma, J Chee, L Islas, A Cessna, ... Proceedings of the National Academy of Sciences 118 (30), e2025570118, 2021 | 40 | 2021 |
| Expression of pro-and antiapoptotic molecules of the Bcl-2 family in human islets postisolation PD Campbell, A Weinberg, J Chee, L Mariana, R Ayala, WJ Hawthorne, ... Cell transplantation 21 (1), 49-60, 2012 | 34 | 2012 |
| Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes HE Thomas, KL Graham, J Chee, R Thomas, TW Kay, B Krishnamurthy Annals of the New York Academy of Sciences 1283 (1), 81-86, 2013 | 33 | 2013 |
| Analysis of antigen specific T cells in diabetes–Lessons from pre-clinical studies and early clinical trials B Krishnamurthy, C Selck, J Chee, G Jhala, TWH Kay Journal of autoimmunity 71, 35-43, 2016 | 26 | 2016 |
| Functional cytotoxic T lymphocytes against IGRP206‐214 predict diabetes in the non‐obese diabetic mouse HJ Ko, J Chee, RM Sutherland, HE Thomas, Y Zhan, B Krishnamurthy, ... Immunology and cell biology 92 (7), 640-644, 2014 | 23 | 2014 |
| Complete diabetes protection despite delayed thymic tolerance in NOD8. 3 TCR transgenic mice due to antigen-induced extrathymic deletion of T cells B Krishnamurthy, J Chee, G Jhala, S Fynch, KL Graham, P Santamaria, ... Diabetes 61 (2), 425-435, 2012 | 22 | 2012 |
| Bim deficiency protects NOD mice from diabetes by diverting thymocytes to regulatory T cells B Krishnamurthy, J Chee, G Jhala, P Trivedi, T Catterall, C Selck, ... Diabetes 64 (9), 3229-3238, 2015 | 21 | 2015 |
| Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens B Wylie, J Chee, CA Forbes, M Booth, SR Stone, A Buzzai, A Abad, ... Oncoimmunology, 2019 | 20 | 2019 |
| Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes G Jhala, J Chee, PM Trivedi, C Selck, EN Gurzov, KL Graham, ... JCI Insight 1 (10), 2016 | 20 | 2016 |
| Granzyme A deficiency breaks immune tolerance and promotes autoimmune diabetes through a type I interferon–dependent pathway ZUA Mollah, HS Quah, KL Graham, G Jhala, B Krishnamurthy, ... Diabetes 66 (12), 3041-3050, 2017 | 19 | 2017 |
| Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies J Chee, BWS Robinson, RA Holt, J Creaney Chest 151 (4), 891-897, 2017 | 18 | 2017 |
| Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used VS Fear, CA Forbes, SA Neeve, SA Fisher, J Chee, J Waithman, SK Ma, ... Cancer Immunology, Immunotherapy, 1-10, 2021 | 17 | 2021 |
